Mirae Asset Global Investments Co., Ltd. Mirum Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $20 Billion
- Q2 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,407 shares of MIRM stock, worth $53,325. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,407
Previous 18,641
92.45%
Holding current value
$53,325
Previous $468,000
89.74%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding MIRM
# of Institutions
172Shares Held
54.2MCall Options Held
96.1KPut Options Held
54.8K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.5MShares$246 Million13.09% of portfolio
-
Janus Henderson Group PLC London, X04.99MShares$189 Million0.09% of portfolio
-
Bvf Inc San Francisco, CA4.37MShares$166 Million4.57% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.61MShares$137 Million2.18% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$123 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.39B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...